Protective role of the novel hybrid 3,5-dipalmitoyl-nifedipine in a cardiomyoblast culture subjected to simulated ischemia/reperfusion

Graphical abstract

Saved in:
Bibliographic Details
Published inBiomedicine & pharmacotherapy Vol. 92; pp. 356 - 364
Main Authors Santa-Helena, Eduarda, Teixeira, Stefanie, Castro, Micheli Rosa de, Cabrera, Diego da Costa, D’Oca, Caroline Da Ros Montes, D’Oca, Marcelo G. Montes, Votto, Ana Paula S, Nery, Luiz Eduardo Maia, Gonçalves, Carla Amorim Neves
Format Journal Article
LanguageEnglish
Published France Elsevier Masson SAS 01.08.2017
Subjects
Animals
Calcium blocker
Calcium Channel Blockers - chemistry
Calcium Channel Blockers - pharmacology
Calcium Channel Blockers - therapeutic use
Cardiotonic Agents - chemistry
Cardiotonic Agents - pharmacology
Cardiotonic Agents - therapeutic use
Cell Survival - drug effects
Cell Survival - physiology
Cells, Cultured
Dose-Response Relationship, Drug
H9c2
Hypoxia
Infarction
Internal Medicine
Medical Education
Myocytes, Cardiac - drug effects
Myocytes, Cardiac - pathology
Nifedipine - chemistry
Nifedipine - pharmacology
Nifedipine - therapeutic use
Palmitic acid
Palmitic Acid - chemistry
Palmitic Acid - pharmacology
Palmitic Acid - therapeutic use
Rats
Rats, Wistar
Reperfusion Injury - pathology
Reperfusion Injury - prevention & control
H9c2
Calcium blocker
Hypoxia
Infarction
Palmitic acid
Online AccessGet full text

Cover

More Information
Summary:Graphical abstract
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0753-3322
1950-6007
DOI:10.1016/j.biopha.2017.05.091